Gentamicin-eluting bioresorbable composite fibers for wound healing applications

Journal of Biomedical Materials Research - Part A

Volumn 89, Issue 3, 2009, Pages 654-666

  Zilberman, Meital ^a   Golerkansky, Esty ^a   Elsner, Jonathan J ^a   Berdicevsky, Israela ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Composite fibers; Controlled drug delivery; Gentamicin; Poly(DL lac Tic co glycolic acid); Wound dressings

Indexed keywords

ANTIBIOTIC AGENTS; BACTERIAL INHIBITION; BACTERIAL STRAINS; BACTERIAL VIABILITY; BASIC ELEMENTS; BIORESORBABLE; BURST RELEASE; COMPOSITE FIBERS; DRUG CONTENT; DRUG RELEASE; FIBER STRUCTURES; FREEZE DRYING; GENTAMICIN; GLYCOLIC ACIDS; PHASE RATIOS; POLY(DL-LAC- TIC-CO-GLYCOLIC ACID); RELEASE PROFILES; RELEASE RATE; WOUND DRESSINGS; WOUND HEALING APPLICATIONS;

ACIDS; BACTERIOLOGY; EMULSIFICATION; FIBERS; SURFACE ACTIVE AGENTS; TEMPERATURE INDICATING CAMERAS;

CONTROLLED DRUG DELIVERY;

ALBUMIN; BIOMATERIAL; GENTAMICIN; MAXON; POLYGLACTIN;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIABILITY; BIOENGINEERING; COLONY FORMING UNIT; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; FREEZE DRYING; MINIMUM INHIBITORY CONCENTRATION; WOUND DRESSING; WOUND HEALING;

BACTERIA; BIOCOMPATIBLE MATERIALS; COLONY COUNT, MICROBIAL; DRUG DELIVERY SYSTEMS; EMULSIONS; GENTAMICINS; MICROBIAL SENSITIVITY TESTS; MICROBIAL VIABILITY; MICROSCOPY, ELECTRON, SCANNING; POLYMERS; SURFACE-ACTIVE AGENTS; WOUND HEALING;

EID: 66249102323     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32013     Document Type: Article

References (24)

1. Revathi G, Puri J, Jaid BK. Bacteriology of burns. Burns 1998;1:347-349.
2. Thorn RMS, Greenman J, Austin AJ. In vitro method to assess the antimicrobial activity and potential efficacy of novel types of wound dressings. J Appl Microbiol 2005; 99:895-901.
3. Heggers J, Goodheart RE, Washington J, McCoy L, Carino E, Dang T, Edgar P, Maness C, Chinkes D. Therapeutic efficacy of three silver dressings in an infected animal model. J Burn Care Rehabil 2005;26:53-56.
4. Fraser JF, Bodman J, Sturgess R, Faoagali J, Kimble RM. An in vitro study of the anti-microbial efficacy of 1% silver sul- phadiazine and 0.2% chlorhexidine digluconate cream, 1% silver sulphadiazine cream and a silver coated dressing. Burns 2004;30:35-41.
5. Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, Hao JY. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002;59:438-449.
6. Su SH, Landau CL, Chao RY, Timmons RB, Meidell RS, Tang L, Eberhart RC. Expandable bioresorbable endovascular stent with anti-platelet and anti-inflammation treatments. Circulation 2001;104:500-507.
7. Alikacem N, Yoshizawa T, Wilson C, Nelson KD. Quantitative MR imaging study of intravitreal sustained release of VEGF in rabbits. Invest Ophthalmol Vis Sci 2000;41:1561-1569.
8. Dunn RL, Lewis DH, Goodson JM. Monolithic fibers for controlled delivery of tetracycline. Proc Int Symp Control Rel Bioact Mater 1982;9:157-163.
9. Dunn RL, English JP, Stoner WC, Potter AG, Perkins BH. Biodegradable fibers for the controlled release of tetracycline in treatment of peridontal disease. Proc Int Symp Control Rel Bioact Mater 1987;14:289-294.
10. Dunn RL, Lewis DH, Beck LR. Fibrous polymer for the delivery of contraceptive steroids to the female reproductive track. In: Lewis DH, editor. Controlled Release of Pesticides and Pharmaceuticals. New York: Plenum Press; 1981. p 125-146.
11. Eenink MDJ, Feijen J, Oligslanger J, Albers JHM, Rieke JC, Greidonus PJ. Biodegradable hollow fibers for the controlled release of hormones. J Control Release 1987;6:225-237.
12. Polacco G, Cascone MG, Lazzeri L, Ferrara S, Giusti P. Biodegradable hollow fibers containing drug-loaded nanoparticles as controlled release systems. Polym Int 2002;51:1464-1472.
13. Lazzeri L, Cascone MG, Quiriconi S, Morabito L, Giusti P. Biodegradable hollow microfibers to produce bioactive scaffolds. Polym Int 2005;54:101-107.
14. Zilberman M. Novel composite fiber structures to provide drug/protein delivery for medical implants and tissue regeneration. Acta Biomater 2007;3:51-57.
15. Kraitzer A, Zilberman M. Paclitaxel-loaded composite fibers: Microstructure and emulsion stability. J Biomed Mater Res 2007;81:427-436.
16. Bibette J, Calderon FL, Poulin P. Emulsions: Basic principles. Rep Prog Phys 1999;62:969-1033.
17. Bencher P. Encyclopedia of Emulsion Technology, Vol 3. New York: Marcel Dekker; 1988.
18. Sjoblom J, editor. Emulsion and Emulsion Stability. New York: Marcel Dekker; 1996.
19. Washington C. Stability of lipid emulsions for drug delivery. Adv Drug Deliv Rev 1996;20:131-140.
20. Sampath SS, Robinson. DH. Comparison of new and existing spectrophotometric methods of analysis of tobramycin and other aminoglycosides. J Pharm Sci 1990;79:428-431.
21. Tentative Standard. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Villoanova, PA: National Committee for Clinical Laboratory Standards, 1983.
22. Wallner JJ. Binding of drugs by albumin and plasma proteins. J Pharm Sci 1977;66:447-465.
23. Foye WO. Principles of Medicinal Chemistry, 3rd ed. Philadelphia: Lea and Febiger; 1998.
24. Ruszak Z, Freiss W. Collagen as carrier for on-site delivery of antibacterial drugs. Adv Drug Deliv Rev 2003;55:1679- 1698.